SymPhysis Medical

SymPhysis Medical is an Irish medtech startup founded in 2018 and based in Galway, Ireland. The company focuses on developing innovative medical technologies aimed at improving the quality of life for patients with chronic conditions, particularly in palliative care for malignant pleural effusion (MPE). Their flagship product, the rel ease™ Drainage System, is a novel fluid drainage device designed for home use, allowing patients to manage their condition independently. This minimally invasive system enhances comfort and promotes self-management, achieving a 95% success rate in clinical studies.

The management team at SymPhysis Medical brings extensive experience from leading medical device companies. The company has successfully raised approximately $6.08 million in funding and plans to launch its products in the US by 2026, targeting significant revenue growth by 2030. SymPhysis is committed to patient-centered development, collaborating with healthcare professionals to validate their technologies and improve outcomes in palliative care settings.